Eisai Launches REVOVIR(R) in the Philippines for the Treatment of Chronic Hepatitis B

  Tokyo, Feb 24, 2010 - (ACN Newswire ) - Eisai Co., Ltd. announced today that the Company's Philippine subsidiary, HI-Eisai Pharmaceutical Inc., launched & quot;REVOVIR(R) 30mg Capsules & quot; (generic name: clevudine) in the Philippines for the treatment of chronic hepatitis B.REVOVIR is a Nucleoside Reverse Transcriptase Inhibitor (NRTI).  

Sydney

  [ Change ]
 
Today

Max: 19°
Shower or two.
Tomorrow

Min: 13°
Max: 20°
Possible shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online